The First Thirty

The First Thirty is a leading venture capital and private equity firm dedicated to fueling the AgriHealth Revolution. With a clear vision for the future, The First Thirty invests in innovative entrepreneurs who are leveraging technology to bridge the gap between agriculture and healthcare. By focusing on enhancing nutrition at the source, preventing toxins, and building transformative platforms, The First Thirty aims to create new industries and drive exceptional returns. The firm operates with a global perspective, seeking out venture-scale opportunities that have the potential to reshape trillion-dollar markets.

The First Thirty is committed to supporting companies that are making traditional healthcare costs obsolete. The firm's investment approach centers around identifying and capitalizing on the arbitrage opportunity where agriculture can deliver health outcomes far more efficiently than traditional healthcare systems. By investing in companies that enhance nutrition, prevent toxins, and build distributed health delivery systems, The First Thirty is at the forefront of transforming the AgriHealth landscape.

Located in London and Amsterdam, The First Thirty is strategically positioned to identify and support groundbreaking ventures in the AgriHealth sector. The company's mission is to drive the AgriHealth Revolution by investing in innovative companies that are creating a healthier and more sustainable future. We encourage the manager of The First Thirty to create a customized and exclusive company showcase and product listing on our platform, to better highlight the company's vision and achievements.